Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$130K Sell
12,403
-1,476
-11% -$16.2K 0.01% 238
2022
Q1
$151K Sell
13,879
-1,576
-10% -$20.8K 0.01% 243
2021
Q4
$209K Sell
15,455
-6,961
-31% -$93K 0.01% 219
2021
Q3
$304K Sell
22,416
-1,864
-8% -$26.4K 0.01% 246
2021
Q2
$347K Sell
24,280
-1,380
-5% -$20K 0.02% 237
2021
Q1
$358K Buy
25,660
+1,537
+6% +$25.1K 0.02% 216
2020
Q4
$452K Buy
+24,123
New +$393K 0.03% 189

Other funds holding VTRS

RBC Europe's VTRS Position: Q2 2022 in Review

RBC Europe reduced its Viatris (VTRS) stake by 11% in Q2 2022, selling an estimated $16.2K and leaving 12,403 shares worth $130K. The position accounts for 0.01% of the portfolio, ranked #238.

RBC Europe first reported a position in VTRS in Q4 2020 and has held it in 7 quarters since. The position peaked at $452K in Q4 2020. 1,012 funds tracked by Wall St. Rank hold VTRS as of Q2 2022.

  • RBC Europe held 12,403 shares of Viatris worth $130K as of Q2 2022.
  • RBC Europe sold 1,476 Viatris shares in Q2 2022, an estimated $16.2K.
  • Viatris made up 0.01% of RBC Europe's portfolio in Q2 2022, its #238 holding.
  • RBC Europe first reported a position in Viatris in Q4 2020 and has held it in 7 quarters since.
  • RBC Europe's Viatris position peaked at $452K in Q4 2020.
  • 1,012 funds tracked by Wall St. Rank held Viatris as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.